Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...
The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...
On second thought, the FDA figures it no longer needs to discuss Exelixis’ application for Cabometyx in neuroendocrine tumors ...
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
Opponents argue that the change could cause current smokers to use more cigarettes to compensate for the lower nicotine ...
CapsoVision announced today that the FDA cleared its CapsoCam Plus system for use in pediatric patients aged two and above.
Years of research have showed that pulse oximeters yield less accurate readings for people with darker skin tones, and now ...
The recalled "Connie's Thin Crust Cheese Pizza" was issued a Class II risk level by the FDA, the second-most severe risk ...
D Molecular Therapeutics reaches agreement with FDA for phase 3 trial design of DME candidate 4D-150, showing promising ...
The FDA has set maximum levels for lead in baby food. A new California law requires baby food makers selling products in the ...
The U.S. food supply is generally considered safe, but tens of millions of people get sick from foodborne illnesses each year ...